Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers

James V. Sitzmann, Yuping Wu, John L. Cameron

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Objective. To characterize angiotensin-II receptor density and affinity in normal and cirrhotic livers and in hepatocellular and metastatic colorectal cancer. Summary Background Data. Several studies have indicated a possible beneficial effect of angiotensin-II as a biologic response modifier in the treatment of hepatic or metastatic colon cancer. This is based on evidence that angiotensin-II will cause a selective increase in arterial vasoconstriction in normal liver compared with tumor. Methods. Human hepatoma (5), metastatic colon (10), or cirrhotic (3) liver was obtained. Non-tumor bearing regions served as normal liver. Angiotensin-II receptor binding was determined on membranes with 125I-angiotensin-II and in situ studies were performed using the biotin-avidin detection system. Results. Angiotensin-II receptor density was markedly down-regulated in tumor compared with normal or cirrhotic liver. Conclusions. A loss of angiotensin-II receptors occurs on the neovasculature of hepatic tumors.

Original languageEnglish (US)
Pages (from-to)500-507
Number of pages8
JournalAnnals of surgery
Issue number5
StatePublished - May 1994

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers'. Together they form a unique fingerprint.

Cite this